DOCETAXEL , MK-2870, VINFLUNINE , PACLITAXEL , MK-2870, -, -
MK-2870-031
Phase 3 small_molecule active
Quick answer
DOCETAXEL , MK-2870, VINFLUNINE , PACLITAXEL , MK-2870, -, - for Locally advanced/metastatic urothelial carcinoma is a Phase 3 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Locally advanced/metastatic urothelial carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active